The move towards more patient-centric medicines requires testing capabilities that go beyond standard methodologies. At SGS, we are ready to help you with a range of personalized testing solutions
Parameters covered include:
- Genetics – with experience in human genetic testing and pharmacogenetics, we will help you to evaluate and identify available methodologies and, if required, develop new solutions. In addition to genetic testing, we also offer a broad spectrum of cell phenotyping (e.g., FACS with up to ten colors) and HLA typing
- Biomarkers – evaluation of biomarkers takes you beyond genetic characterization and is a useful way to stratify patients. We offer a comprehensive range of established and validated test methods for biomarkers. Our experts understand different matrices (CSF, sputum, tissue, etc.) and are ready to identify and develop biomarkers that fit your purpose. They can evaluate a broad variety of cytokines, from specific markers to complex cytokine profiles using individual tests or multiplex systems that offer a cost-effective, tailored approach that meets your needs
- PBMC/BMMC – typing and functional testing of peripheral blood mononuclear cells (PBMC) or bone marrow mononuclear cells (BMMC) is a powerful characterization tool for which we also offer cell isolation and cryopreservation. As part of a global PBMC network, we will help you overcome the logistical challenges and project-specific isolation protocols associated with PBMC and BMMC testing
Why choose advanced specialty laboratory testing solutions from SGS?
We are recognized as the benchmark for quality and integrity in clinical trial services. With over 25 years of experience and more than 3,000 completed clinical studies and projects, our solutions incorporate established and validated methodologies with personalized tests to ensure you have the data you need to safely and successfully complete your clinical trial.